VI
GBT

Versor Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Versor Investments’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-641,904
Closed -$43.7M – 1048
2022
Q3 		$43.7M Buy
+641,904
New +$35.4M 2.6% 12

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Versor Investments's GBT Position: Q4 2022 in Review

Versor Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 641,904 shares — an estimated $43.7M sold.

Versor Investments first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $43.7M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Versor Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Versor Investments sold 641,904 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $43.7M.
  • Versor Investments first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Versor Investments's Global Blood Therapeutics, Inc. position peaked at $43.7M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Versor Investments's 13F filing for Q4 2022, filed 30 Jan 2023.